FDA inspection
Intas Pharmaceuticals Limited: FDA inspection ending Jul 12, 2024
FDA inspection 1245599 · No Action Indicated (NAI) · Ahmedabad
Key facts
| Inspection ID | 1245599 |
|---|---|
| Firm | Intas Pharmaceuticals Limited |
| FEI number | 3003157498 |
| Address | Plot No. 457/458-Matoda / Plot No.191/218P-Chacharwadi , Sarkhej-Bavla Highway, Taluka-Sanand |
| City | Ahmedabad |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Jul 12, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data